CHST3-related skeletal dysplasia
General Information (adopted from Orphanet):
Synonyms, Signs: |
CHONDRODYSPLASIA WITH MULTIPLE DISLOCATIONS SPONDYLOEPIPHYSEAL DYSPLASIA, OMANI TYPE HUMEROSPINAL DYSOSTOSIS HSD CDMD Spondyloepiphyseal dysplasia with congenital joint dyslocations, CHST3 type Autosomal recessive Larsen syndrome Chondrodysplasia with congenital joint dislocations, CHST3 type SDCD, CHST3 type |
Number of Symptoms | 119 |
OrphanetNr: | 263463 |
OMIM Id: |
143095
|
ICD-10: |
Q74.8 |
UMLs: |
|
MeSH: |
|
MedDRA: |
|
Snomed: |
|
Prevalence, inheritance and age of onset:
Prevalence: | No data available. |
Inheritance: |
Autosomal recessive [Orphanet] |
Age of onset: |
Neonatal Infancy [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
Congenital disorder of glycosylation-related bone disorder
-Rare developmental defect during embryogenesis -Rare genetic disease Disorder of O-xylosylglycan synthesis -Rare genetic disease Primary bone dysplasia with multiple joint dislocations -Rare bone disease -Rare developmental defect during embryogenesis -Rare genetic disease |
Symptom Information:
|
(HPO:0000343) | Long philtrum | Frequent [HPO:probinson] | 262 / 7739 | |||
|
(HPO:0000337) | Broad forehead | Frequent [HPO:probinson] | 116 / 7739 | |||
|
(HPO:0000687) | Widely spaced teeth | 40 / 7739 | ||||
|
(HPO:0000470) | Short neck | 345 / 7739 | ||||
|
(HPO:0000691) | Microdontia | 104 / 7739 | ||||
|
(HPO:0000218) | High palate | 356 / 7739 | ||||
|
(HPO:0000316) | Hypertelorism | 644 / 7739 | ||||
|
(HPO:0000684) | Delayed eruption of teeth | 117 / 7739 | ||||
|
(HPO:0002553) | Highly arched eyebrow | Frequent [HPO:probinson] | 92 / 7739 | |||
|
(HPO:0000535) | Sparse and thin eyebrow | Frequent [HPO:probinson] | 76 / 7739 | |||
|
(HPO:0008551) | Microtia | 98 / 7739 | ||||
|
(HPO:0000365) | Hearing impairment | 539 / 7739 | ||||
|
(HPO:0002515) | Waddling gait | 56 / 7739 | ||||
|
(HPO:0002194) | Delayed gross motor development | 37 / 7739 | ||||
|
(HPO:0006610) | Wide intermamillary distance | 46 / 7739 | ||||
|
(HPO:0002967) | Cubitus valgus | 49 / 7739 | ||||
|
(HPO:0001552) | Barrel-shaped chest | 31 / 7739 | ||||
|
(HPO:0009803) | Short phalanx of finger | 79 / 7739 | ||||
|
(HPO:0003042) | Elbow dislocation | 89 / 7739 | ||||
|
(HPO:0100490) | Camptodactyly of finger | 212 / 7739 | ||||
|
(HPO:0000954) | Single transverse palmar crease | 162 / 7739 | ||||
|
(HPO:0012385) | Camptodactyly | 113 / 7739 | ||||
|
(HPO:0006487) | Bowing of the long bones | 95 / 7739 | ||||
|
(HPO:0002750) | Delayed skeletal maturation | 250 / 7739 | ||||
|
(HPO:0003022) | Hypoplasia of the ulna | 40 / 7739 | ||||
|
(HPO:0003040) | Arthropathy | 19 / 7739 | ||||
|
(HPO:0003834) | Shoulder dislocation | 28 / 7739 | ||||
|
(HPO:0006067) | Multiple carpal ossification centers | 2 / 7739 | ||||
|
(HPO:0001762) | Talipes equinovarus | 309 / 7739 | ||||
|
(HPO:0010049) | Short metacarpal | 99 / 7739 | ||||
|
(HPO:0100864) | Short femoral neck | 36 / 7739 | ||||
|
(HPO:0001763) | Pes planus | 176 / 7739 | ||||
|
(HPO:0002945) | Intervertebral space narrowing | 7 / 7739 | ||||
|
(HPO:0009882) | Short distal phalanx of finger | 125 / 7739 | ||||
|
(HPO:0003417) | Coronal cleft vertebrae | 14 / 7739 | ||||
|
(HPO:0002808) | Kyphosis | 289 / 7739 | ||||
|
(HPO:0006471) | Fixed elbow flexion | 1 / 7739 | ||||
|
(HPO:0010585) | Small epiphyses | 16 / 7739 | ||||
|
(HPO:0003093) | Limited hip extension | 4 / 7739 | ||||
|
(HPO:0002829) | Arthralgia | 79 / 7739 | ||||
|
(HPO:0001836) | Camptodactyly of toe | 27 / 7739 | ||||
|
(HPO:0004976) | Knee dislocation | 6 / 7739 | ||||
|
(HPO:0003071) | Flattened epiphysis | 14 / 7739 | ||||
|
(HPO:0002982) | Tibial bowing | 36 / 7739 | ||||
|
(HPO:0008450) | Narrow vertebral interpedicular distance | 6 / 7739 | ||||
|
(HPO:0002751) | Kyphoscoliosis | 131 / 7739 | ||||
|
(HPO:0003031) | Ulnar bowing | 16 / 7739 | ||||
|
(HPO:0003301) | Irregular vertebral endplates | 25 / 7739 | ||||
|
(HPO:0002655) | Spondyloepiphyseal dysplasia | 21 / 7739 | ||||
|
(HPO:0003090) | Hypoplasia of the capital femoral epiphysis | 15 / 7739 | ||||
|
(HPO:0002857) | Genu valgum | 144 / 7739 | ||||
|
(HPO:0006462) | Generalized bone demineralization | 11 / 7739 | ||||
|
(HPO:0002650) | Scoliosis | 705 / 7739 | ||||
|
(HPO:0003184) | Decreased hip abduction | 7 / 7739 | ||||
|
(HPO:0001156) | Brachydactyly syndrome | 180 / 7739 | ||||
|
(HPO:0002938) | Lumbar hyperlordosis | 73 / 7739 | ||||
|
(HPO:0007598) | Bilateral single transverse palmar creases | 13 / 7739 | ||||
|
(HPO:0001215) | Camptodactyly of 2nd-5th fingers | 8 / 7739 | ||||
|
(HPO:0008905) | Rhizomelia | 85 / 7739 | ||||
|
(HPO:0009179) | Deviation of the 5th finger | 1 / 7739 | ||||
|
(HPO:0001653) | Mitral regurgitation | 64 / 7739 | ||||
|
(HPO:0005180) | Tricuspid regurgitation | 20 / 7739 | ||||
|
(HPO:0001718) | Mitral stenosis | 10 / 7739 | ||||
|
(HPO:0001650) | Aortic valve stenosis | 49 / 7739 | ||||
|
(HPO:0002092) | Pulmonary hypertension | 109 / 7739 | ||||
|
(HPO:0001629) | Ventricular septal defect | 316 / 7739 | ||||
|
(HPO:0001659) | Aortic regurgitation | 36 / 7739 | ||||
|
(HPO:0010446) | Tricuspid stenosis | 5 / 7739 | ||||
|
(HPO:0001642) | Pulmonic stenosis | 89 / 7739 | ||||
|
(HPO:0001714) | Ventricular hypertrophy | 20 / 7739 | ||||
|
(OMIM) | Knee extension limited | 1 / 7739 | ||||
|
(OMIM) | Small flat epiphyses | 2 / 7739 | ||||
|
(OMIM) | Length <3rd percentile by 6 months | 1 / 7739 | ||||
|
(OMIM) | Kyphoscoliosis, severe progressive (>12 years old) | 1 / 7739 | ||||
|
(OMIM) | Mitral regurgitation, mild to moderate | 1 / 7739 | ||||
|
(OMIM) | Interpedicular distance widened at L1 on anteroposterior projection | 1 / 7739 | ||||
|
(OMIM) | Endplate irregularity, progressive | 1 / 7739 | ||||
|
(OMIM) | Hunched up shoulders (more prominent in adults) | 1 / 7739 | ||||
|
(OMIM) | Interpedicular distance narrowed in lumbar area | 1 / 7739 | ||||
|
(OMIM) | Aortic valve, mild stenosis | 1 / 7739 | ||||
|
(OMIM) | Tricuspid valve, thickening to severe stenosis | 1 / 7739 | ||||
|
(OMIM) | Joint dislocations, congenital or in young adult (knee, hip, shoulder) | 1 / 7739 | ||||
|
(OMIM) | Joint contractures, onset school age (shoulder, ankle) | 1 / 7739 | ||||
|
(OMIM) | Intervertebral space narrowing, progressive | 1 / 7739 | ||||
|
(OMIM) | Accessory ossification centers | 1 / 7739 | ||||
|
(OMIM) | Birth length normal | 15 / 7739 | ||||
|
(OMIM) | Variable metacarpal shortening | 1 / 7739 | ||||
|
(MedDRA:10072883) | Brachydactyly | 153 / 7739 | ||||
|
(OMIM) | Adult height 110-130cm | 1 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 | ||||
|
(HPO:0000006) | Autosomal dominant inheritance | 2518 / 7739 | ||||
|
(OMIM) | Limited hip abduction/extension (progressive from birth) | 1 / 7739 | ||||
|
(OMIM) | Arthropathy, progressive | 1 / 7739 | ||||
|
(OMIM) | Delayed dentition | 5 / 7739 | ||||
|
(OMIM) | Long bones of legs, hypotubulation of | 1 / 7739 | ||||
|
(OMIM) | Normal intelligence | 81 / 7739 | ||||
|
(OMIM) | Iliac bones prominent | 1 / 7739 | ||||
|
(OMIM) | Joint enlargement (knee, elbow, wrist) | 1 / 7739 | ||||
|
(OMIM) | Ulna, proximal bowing | 1 / 7739 | ||||
|
(OMIM) | Aortic regurgitation, moderate | 1 / 7739 | ||||
|
(OMIM) | Iliac bones widened | 1 / 7739 | ||||
|
(OMIM) | Elbow dislocation/subluxation | 1 / 7739 | ||||
|
(OMIM) | Ulna, shortened | 1 / 7739 | ||||
|
(OMIM) | Humerus, distal bifurcation (in some patients) | 1 / 7739 | ||||
|
(OMIM) | Short stature, prenatal and postnatal | 1 / 7739 | ||||
|
(OMIM) | Short and cleft vertebral bodies on lateral projection | 1 / 7739 | ||||
|
(OMIM) | Mitral valve, thickening to severe stenosis | 1 / 7739 | ||||
|
(OMIM) | Tricuspid regurgitation, moderate | 1 / 7739 | ||||
|
(OMIM) | Accessory carpal ossification centers | 1 / 7739 | ||||
|
(OMIM) | Capital femoral epiphyses, hypoplasia of | 1 / 7739 | ||||
|
(OMIM) | Knee dislocation/subluxation | 1 / 7739 | ||||
|
(OMIM) | Sparse and high-arched eyebrows (in some patients) | 1 / 7739 | ||||
|
(OMIM) | Pulmonary valve, mild stenosis | 1 / 7739 | ||||
|
(OMIM) | Tibia, anterolateral bowing | 1 / 7739 | ||||
|
(OMIM) | Rhizomelic shortening | 12 / 7739 | ||||
|
(OMIM) | Hypertrophy of all 4 chambers of heart | 1 / 7739 | ||||
|
(OMIM) | Vertebral body notching, superior and inferior | 1 / 7739 | ||||
|
(OMIM) | Diffuse osseous demineralization | 1 / 7739 | ||||
|
(OMIM) | Interdigital skin webs | 1 / 7739 |
Associated genes:
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
Although patients with mutations in the CHST3 gene may initially be given varying diagnostic labels, they have similar clinical features, including dislocation of the knees and/or hips at birth, clubfoot, elbow joint dysplasia with subluxation and limited extension, ... |
Clinical Description OMIM |
Kozlowski et al. (1974) described 2 half sibs with an unusual skeletal dysplasia of which short humerus with distal bifurcation was one of the more striking features. Other features included coronal cleft vertebrae, subluxation in the elbow joints, ... |
Molecular genetics OMIM |
In affected members of the consanguineous Omani kindred with spondyloepiphyseal dysplasia (SED) originally described by Rajab et al. (2004), Thiele et al. (2004) identified homozygosity for a missense mutation in the CHST3 gene (R304Q; 608637.0001). They concluded that ... |
Diagnosis GeneReviews | The diagnosis of CHST3-related skeletal dysplasia is based on the combination of characteristic clinical and radiographic signs and confirmation by molecular genetic testing. ... Gene SymbolTest MethodMutations DetectedMutation Detection Frequency by Test Method 1Test AvailabilityCHST3Sequence analysis | Sequence variants 2>90% 3Clinical1. The ability of the test method used to detect a mutation that is present in the indicated gene2. Examples of mutations detected by sequence analysis may include small intragenic deletions/insertions and missense, nonsense, and splice site mutations.3. The high detection rate applies only to those individuals with clear clinical and radiographic changes consistent with CHST3 deficiency and not to an unselected population of children with joint dislocations.Interpretation of test results. For issues to consider in interpretation of sequence analysis results, click here.Testing Strategy To confirm/establish the diagnosis in a probandClinical and radiologic features can strongly suggest the diagnosis of CHST3-related skeletal dysplasia [Hermanns et al 2008, Unger et al 2010].Molecular genetic testing by sequencing of the entire coding region is the confirmatory method of choice and allows for precise diagnosis and genetic counseling in the large majority of cases. Biochemical testing of radioactive sulfate incorporation in patient fibroblasts can be useful in those cases in which mutations are not identified or sequence changes of unclear significance have been detected. The diminished sulfation at carbon 6 of proteoglycans offers unambiguous evidence of CHST3 deficiency [Hermanns et al 2008, van Roij et al 2008].Carrier testing for at-risk relatives requires prior identification of the disease-causing mutations in the family.Note: Carriers are heterozygotes for this autosomal recessive disorder and are not at risk of developing the disorder.Prenatal diagnosis and preimplantation genetic diagnosis (PGD) for at-risk pregnancies require prior identification of the disease-causing mutations in the family.Genetically Related (Allelic) Disorders No other phenotypes are known to be associated with mutations in CHST3.
Clinical Description GeneReviews | Most children with CHST3-related skeletal dysplasia are identified at birth as having a generalized skeletal disorder. The features of this disorder are generally limited to the skeleton and joints and are progressive in nature. ... |
Genotype-Phenotype Correlations GeneReviews | No genotype-phenotype correlations have been observed. The phenotype reported thus far has been strikingly homogeneous regardless of type of CHST3 mutation [Unger et al 2010]. Persons with homozygous missense mutations are no less severely affected than those with nonsense mutations. ... |
Differential Diagnosis GeneReviews | Larsen syndrome (autosomal dominant). Multiple dislocations are often the first sign appreciated by the physician and thus CHST3-related skeletal dysplasia may be mistaken for Larsen syndrome early in the evaluation of an affected individual. See FLNB-Related Disorders.... |
Management GeneReviews | To establish the extent of disease in an individual diagnosed with CHST3-related skeletal dysplasia, the following evaluations are recommended:... |
Molecular genetics GeneReviews |
Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED.... Gene SymbolChromosomal LocusProtein NameLocus SpecificHGMDCHST310q22 | Carbohydrate sulfotransferase 3CHST3 @ LOVDCHST3Data are compiled from the following standard references: gene symbol from HGNC; chromosomal locus, locus name, critical region, complementation group from OMIM; protein name from UniProt. For a description of databases (Locus Specific, HGMD) to which links are provided, click here.Table B. OMIM Entries for CHST3-Related Skeletal Dysplasia (View All in OMIM) View in own window 143095SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS 603799CARBOHYDRATE SULFOTRANSFERASE 3; CHST3Normal allelic variants. CHST3 is a relatively small gene, comprising three exons. Pathologic allelic variants. Several recurrent mutations have been identified in families of similar ethnic background and, thus, may represent founder mutations [Unger et al 2010]. No hot spots have been identified but the majority of known mutations are clustered in the sulfotransferase domain. Normal gene product. Carbohydrate sulfotransferase 3 is the enzyme responsible for the transfer of sulfate from PAPS to position 6 of N-acetyl galactosamine. Proper sulfation of the chondroitin sulfate proteoglycans is essential for normal cartilage structure.Abnormal gene product. Sulfation studies as well as the nature of the known mutations and the mode of inheritance suggest that the pathogenesis of the disorder results from decreased/absent catalytic activity of the enzyme.